Viral gene transfer of the antiapoptotic factor Bcl-2 protects against chronic postischemic heart failure

Circulation

Volumn 106, Issue 13 SUPPL., 2002, Pages

  Chatterjee, Subhasis ^a   Stewart, Allan S ^a   Bish, Lawrence T ^a   Jayasankar, Vasant ^a   Kim, Elizabeth M ^a   Pirolli, Timothy ^a   Burdick, Jeffrey ^a   Woo, Y Joseph ^a   Gardner, Timothy J ^a   Sweeney, H Lee ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; Gene therapy; Heart failure; Myocardial infarction; Remodeling

Indexed keywords

PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CELL VIABILITY; CHRONIC DISEASE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE TRANSFER; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VIRUS GENE;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CHRONIC DISEASE; ECHOCARDIOGRAPHY; GENE THERAPY; GENES, BCL-2; GENETIC VECTORS; HEART FAILURE, CONGESTIVE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PROTO-ONCOGENE PROTEINS C-BCL-2; RABBITS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 0037167707     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79:215-262.
2. Anversa P, Ricci R, Olivetti G. Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review. J Am Coll Cardiol. 1986;7:1140-1149.
3. Olivetti G, Capasso JM, Sonnenblick EH, et al. Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res. 1990;67:23-34.
4. Cheng W, Li B, Kajstura J, et al. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995;96:2247-2259.
5. Weisman HF, Bush DE, Mannisi JA, et al. Cellular mechanisms of myocardial infarct expansion. Circulation. 1988;78:186-201.
6. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 1996;79:949-956.
7. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human Heart. N Engl J Med. 1997;336:1131-1141.
8. Olivetti G, Capasso JM, Meggs LG, et al. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res. 1991;68:856-869.
9. Chen C, Linfert DR, Lai L, et al. Myocardial cell death and apoptosis in hibernating myocardium. J Am Coll Cardiol. 1997;30:1407-1412.
10. Anversa P, Cheng W, Liu Y, et al. Apoptosis and myocardial infarction. Basic Res Cardiol. 1998:93(suppl 3):8-12.
11. Saraste A, Pulkki K, Kallajoki M, et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest. 1999;29:380-386.
12. Olivetti G, Quaini F, Sala R, et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol. 1996;28:2005-2016.
13. Fliss H. Accelerated apoptosis in reperfused myocardium: friend or FOE? Basic Res Cardiol. 1998;93:90-93.
14. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309-1312.
15. Garcia-Ruiz C, Colell A, Mari M, et al. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species; role of mitochondrial glutathione. J Biol Chem. 1997;272:11369-11377.
16. Adachi S, Cross AR, Babior BM, et al. Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during Fas-mediated apoptosis. J Biol Chem. 1997;272:21878-21882.
17. Carswell EA, Old LJ, Kassell RL, et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975;72:3666-3670.
18. Cohen GM. Caspases: the executioners of apoptosis. Biochem. J. 1997;326:1-16.
19. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322-1326.
20. Otter I, Conus S, Ravn U. et al. The binding properties and the biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli. J Biol Chem. 1998;273:6110-6120.
21. Gross A, Jockel J, Wei MC, et al. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 1998;3878-3885.
22. DiLisa F, Menabo R, Canton M, et al. The role of mitochondria in the salvage and injury of the ischemic myocardium. Biochim Biophys Acta. 1998;1366:69-78.
23. deMoissic D. Mustapa S, Greenberg AH, et al. Bcl-2 activates the transcription factor NF-kappaB THROUGH the degradation of the cytoplasmic inhibitor I-kappa-B-alpha. J Biol Chem. 1998;273:23946-23951.
24. Vivaldi MT, Kloner RA, Schoen FJ. Triphenyltetrazolium STAINING of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol. 1985;121:522-530.
25. Kirshenbaum LA, deMoissac D. The Bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation. 1997;96:1580-1585.
26. Gottlieb RA, Burleson KO, Kloner RA, et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Investig. 1994;94:1621-1628.
27. Pan J, Fukuda K, Saito M, et al. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res. 1999;84:1127-1136.
28. Leri A, Claudio PP, Li Q, et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest. 1998;101:1326-1342.
29. Ohtsuka T, Hamada M, Hiasa G, et al. Effect of β-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2001;37:412-417.
30. Maury CPJ, Teppo AM. Circulating tumour necrosis factor-α (cachectin) in myocardial infarction. J Intern Med. 1989;225:333-336.
31. Lefer AM, Tsao P, Aoki N. Mediation of cardioprotection by transforming growth factor-β. Science 1990;249:61-64.
32. Bang SH, Jeong EJ, Kim IK, et al. Fas- and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction: A typical model for convergent signal transduction. J Biol Chem. 2000;275:36217-36222.